RecruitingNot ApplicableNCT05779605

Telerehabilitation in Hemato-oncological Survivors

Remotely Monitored Rehabilitation in Hemato-oncological Survivors After Treatment: The Tele@Home Study


Sponsor

Brno University Hospital

Enrollment

80 participants

Start Date

Apr 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

This study investigates whether the 12-week home-based exercise training with remote guidance and telemonitoring compared to regular center-based training leads to better long-term cardiorespiratory fitness and physical activity levels in post-treatment patients with lymphoma.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether an online exercise rehabilitation program (telerehabilitation) delivered via video can help blood cancer or lymphoma survivors regain physical fitness and quality of life after completing chemotherapy. **You may be eligible if:** - You have been diagnosed with a blood cancer or lymphoma within the last two months - You have recently completed chemotherapy-based treatment - Your condition is clinically stable - You are able to perform a cardiopulmonary exercise test (a fitness assessment) - You can read, write, and understand Czech - You have internet access at home and basic comfort with technology **You may NOT be eligible if:** - You have had a serious heart condition or heart failure in the past six weeks - You have severe psychological or cognitive impairments - You have serious physical conditions that limit your ability to exercise safely Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHome-based training

Patients will be instructed to perform three weekly training sessions at home (30 to 50 min/session, at an intensity of 70-85% of their maximum heart rate). Patients in the home training group complete the first three training sessions in the clinic under direct supervision. During these sessions, patients are introduced to the duration and intensity of training. The trainer will provide remote guidance (feedback on training frequency, duration, and intensity) via telephone call once a week. During exercise, patients will use a wearable heart rate monitor (Polar M430, a commercially available device designed for long-term use). Patients will be instructed to properly use the wearable sensor and upload training data to a web-based platform (Polar Flow) via the Internet. Furthermore, patients will be asked to choose their preferred training modality at home (cycling, walking, Nordic walking) and receive instructions and advice.

DEVICECenter-based training

Patients receive three training sessions a week with 30 to 50 min duration at 70 - 90% of their maximal heart rate at the outpatient clinic under direct supervision. Exercise modalities will be walking on a treadmill, riding a bicycle ergometer, and resistance training. Physiotherapists will track the attendance rate and training adherence during the training program.


Locations(1)

University Hospital Brno

Brno, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05779605


Related Trials